Novo Nordisk Blocks Pharmacy's GLP-1 Nasal Spray
A Dutch court has granted Novo Nordisk AS an injunction, ordering a European pharmacy to stop selling a tailored nasal spray that contains the patented active ingredient used in Ozempic. ...To view the full article, register now.
Already a subscriber? Click here to view full article